Daniel W. Muehl
2021 - Clovis Oncology
In 2021, Daniel W. Muehl earned a total compensation of $1.2M as EVP and Chief Financial Officer at Clovis Oncology, a 11% decrease compared to previous year.
Compensation breakdown
| Bonus | $181,563 |
|---|---|
| Salary | $481,818 |
| Stock Awards | $504,630 |
| Other | $22,670 |
| Total | $1,190,681 |
Muehl received $504.6K in stock awards, accounting for 42% of the total pay in 2021.
Muehl also received $181.6K in bonus, $481.8K in salary and $22.7K in other compensation.
Rankings
In 2021, Daniel W. Muehl's compensation ranked 8,145th out of 12,415 executives tracked by ExecPay. In other words, Muehl earned more than 34.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,145 out of 12,415 | 34th |
Division Manufacturing | 3,604 out of 5,505 | 35th |
Major group Chemicals And Allied Products | 1,601 out of 2,375 | 33rd |
Industry group Drugs | 1,424 out of 2,096 | 32nd |
Industry Pharmaceutical Preparations | 1,059 out of 1,546 | 32nd |
Pay ratio
| Daniel W. Muehl's Pay | $1,190,681 |
|---|---|
| Median Employee's Pay | $246,936 |
| Pay Ratio | 5to 1 |
In 2021, the annual total compensation of Daniel W. Muehl was $1,190,681.
The annual total compensation of the median employee at Clovis Oncology was $246,936.
The ratio of Daniel W. Muehl's pay to the pay of median employee was therefore 5 to one.
Source: SEC filing on April 27, 2022.
Muehl's colleagues
We found four more compensation records of executives who worked with Daniel W. Muehl at Clovis Oncology in 2021.
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019